Early clinical trial data in for whole virus COVID-19 vaccine candidate

By | August 19, 2021
In a study uploaded to the preprint server medRxiv*, the efficacy of a whole virion Coronavirus vaccine was determined by giving the vaccine to healthy adult volunteers, which generated a robust immune response with evidence of T-cell activation.